{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Grifols, S.A."},"Symbol":{"label":"Symbol","value":"GRFS"},"Address":{"label":"Address","value":"Spain"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine we develop produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic rare and prevalent diseases sometimes life-threatening drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology hepatology and intensive care pulmonology hematology neurology and infectious diseases. With a workforce of over 27000 employees in more than 30 countries and regions we are committed to a sustainable business model that sets the standard for continuous innovation quality safety and ethical leadership in the industry."},"CompanyUrl":{"label":"Company Url","value":"https://www.grifols.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Albert Grifols Coma-Cros","title":"Director"},{"name":"Nacho Abia","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}